$SCHW

Murtagh Nigel J sold $3.4M of SCHW

Murtagh Nigel J (Chief Risk Officer) sold 32,947 shares of SCHWAB CHARLES CORP (SCHW) at an average of $104.01 ($104.00–$104.03, $3.43M total) across 2 trades on 2026-07-27 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Murtagh Nigel J
Published Jul 30, 2026, 12:20 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 30, 2026, 12:31 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$SCHW
Neutral
high confidence
Mentioned
$SCHW
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SCHWNeutralLow
01

Why it matters

The newest fact is the reported open-market sale amount and timing, but it is explicitly under a pre-arranged 10b5-1 plan, reducing interpretive weight for near-term fundamentals.

02

Market read

Traders may note the insider sale for sentiment monitoring, but there is no new company-specific operating or regulatory catalyst.

03

What to watch

The article does not state the insider’s total compensation, tax-motivated selling, or whether other insiders are selling/buying around the same period, limiting inference.

Relevance 5/10Novelty 3/10Timing: SEC Form 4 filed 2026-07-29 for 2026-07-27 insider sale.

Background

The article is an SEC Form 4 insider transaction disclosure for Charles Schwab (SCHW).

Company-level read

Ticker impact

$SCHWNeutralHigh confidence
Context

Charles Schwab insider Chief Risk Officer Murtagh Nigel J sold 32,947 shares in open-market trades at about $104 on 2026-07-27 under a 10b5-1 plan.

Expected impact

Likely minimal near-term price impact; any effect is more about signaling than fundamentals.

Evidence & confidence

The filing is a Form 4 insider transaction with a pre-arranged 10b5-1 plan, and the article provides no accompanying company-specific news (earnings, guidance, legal, or deal).

Market effects

None. The disclosure is company-specific and does not change broader financial-sector expectations.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, some traders may interpret repeated insider selling as a mild bearish signal, especially if paired with other negative disclosures (not present here).

Key entities

  • SCHW

    Charles Schwab Corporation, the subject of the Form 4 insider sale disclosure.

  • Murtagh Nigel J

    Chief Risk Officer who sold 32,947 shares in open-market trades on 2026-07-27 under a 10b5-1 plan.

Related articles

$SCHWMed

Why Charles Schwab Stock Jumped in July

Charles Schwab (SCHW) shares rose more than 14% in July after the firm reported Q2 results and analysts raised price targets. Schwab said net revenue was $7.1B (+21% YoY), GAAP net income $2.80B (+32%), and raised full-year revenue growth guidance to 17.5% to 18%. STAX hit a multi-year high above 59 in June.

$SCHWMed

Custodians curb long-short SMA strategies

Policy changes from custodians Schwab and Fidelity have advisors and asset managers rethinking strategies around long-short separately managed accounts (SMAs), which involves buying long equity positions while also selling short on underperforming stocks to offset capital gains for wealthy clients.